drugset / Trial / NCT03709745
Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Comparing time to recurrence of macular edema after an initial loading dose of at least three monthly anti VEGF injections (aflibercept or ranibizumab) for macular edema in BRVO.
Timeline
- Start
- 2018-10-18
- Primary completion
- 2021-10-15
- Completion
- 2022-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aflibercept | Protein / enzyme biologic | — | Intravitreal |
| Comparator | Ranibizumab | Monoclonal antibody | — | Intravitreal |